PMF-seq: a highly scalable screening strategy for linking genetics to mitochondrial bioenergetics

Tsz-Leung To,Jason G. McCoy,Naomi K. Ostriker,Lev S. Sandler,Carmen A. Mannella,Vamsi K. Mootha
DOI: https://doi.org/10.1038/s42255-024-00994-0
IF: 19.865
2024-02-28
Nature Metabolism
Abstract:Our current understanding of mitochondrial organelle physiology has benefited from two broad approaches: classically, cuvette-based measurements with suspensions of isolated mitochondria, in which bioenergetic parameters are monitored acutely in response to respiratory chain substrates and inhibitors 1,2,3,4 , and more recently, highly scalable genetic screens for fitness phenotypes associated with coarse-grained properties of the mitochondrial state 5,6,7,8,9,10 . Here we introduce permeabilized-cell mitochondrial function sequencing (PMF-seq) to combine strengths of these two approaches to connect genes to detailed bioenergetic phenotypes. In PMF-seq, the plasma membranes within a pool of CRISPR mutagenized cells are gently permeabilized under conditions that preserve mitochondrial physiology, where detailed bioenergetics can be probed in the same way as with isolated organelles. Cells with desired bioenergetic parameters are selected optically using flow cytometry and subjected to next-generation sequencing. Using PMF-seq, we recover genes differentially required for mitochondrial respiratory chain branching and reversibility. We demonstrate that human d -lactate dehydrogenase specifically conveys electrons from d -lactate into cytochrome c to support mitochondrial membrane polarization. Finally, we screen for genetic modifiers of tBID, a pro-apoptotic protein that acts directly and acutely on mitochondria. We find the loss of the complex V assembly factor ATPAF2 acts as a genetic sensitizer of tBID's acute action. We anticipate that PMF-seq will be valuable for defining genes critical to the physiology of mitochondria and other organelles.
endocrinology & metabolism
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to systematically connect genes with mitochondrial physiological characteristics by developing a technique named PMF - seq (permeabilized - cell mitochondrial function sequencing), which combines the advantages of classical bioenergetics research and high - throughput genetic screening. Specifically, PMF - seq aims to: 1. **Improve the resolution of mitochondrial bioenergetics research**: Traditional methods, such as bioenergetics measurements using isolated mitochondria, can provide detailed bioenergetics parameters but have a low throughput; while high - throughput genetic screening can quickly identify genes that affect mitochondrial function but lack detailed bioenergetics information. PMF - seq gently permeabilizes the plasma membrane in a pool of CRISPR - mutated cells, retaining mitochondrial physiological functions while allowing the addition of specific substrates and inhibitors, thereby achieving high - throughput and high - resolution mitochondrial function analysis. 2. **Reveal the genetic basis of mitochondrial respiratory chain branching and reversibility**: The mitochondrial respiratory chain is not a simple linear sequence but a highly branched structure, with multiple input points into coenzyme Q and cytochrome c. Traditional CRISPR screening cannot analyze in detail the genetic requirements of these branching pathways. PMF - seq can specifically identify genes involved in different branching pathways by controlling the substrate and inhibitor environment. 3. **Explore the mechanism of d - lactate as a respiratory fuel**: Human d - lactate dehydrogenase (LDHD) has been shown to directly transfer electrons from d - lactate to cytochrome c in yeast and plants, but its role in human cells is still unclear. PMF - seq uses d - lactate as a substrate and verifies that LDHD can indeed support the generation of mitochondrial membrane potential in human cells. 4. **Identify genetic modifiers of the acute effect of tBID**: tBID is a pro - apoptotic protein that can directly act on mitochondria to induce apoptosis. PMF - seq is used to screen for genes that have a significant impact on mitochondrial function under tBID treatment, and in particular, it has been found that the deletion of ATPAF2 (complex V assembly factor) enhances the effect of tBID, leading to severe impairment of mitochondrial function. In summary, the PMF - seq technique aims to systematically analyze key genes and their functions in mitochondrial physiology through high - throughput and high - resolution methods, providing new tools and insights for the mechanism research and treatment of mitochondrial - related diseases.